Naderalvojoud Behzad, Shah Nilpa D, Mutanga Jane N, Belov Artur, Staiger Rebecca, Chen Jonathan H, Whitaker Barbee, Hernandez-Boussard Tina
Department of Medicine, Stanford University, Stanford, CA 94305, USA.
Stanford Center for Biomedical Informatics Research, Stanford, CA 94305, USA.
Vaccines (Basel). 2023 Nov 11;11(11):1712. doi: 10.3390/vaccines11111712.
Seasonal influenza is a leading cause of death in the U.S., causing significant morbidity, mortality, and economic burden. Despite the proven efficacy of vaccinations, rates remain notably low, especially among Medicaid enrollees. Leveraging Medicaid claims data, this study characterizes influenza vaccination rates among Medicaid enrollees and aims to elucidate factors influencing vaccine uptake, providing insights that might also be applicable to other vaccine-preventable diseases, including COVID-19. This study used Medicaid claims data from nine U.S. states (2016-2021], encompassing three types of claims: fee-for-service, major Medicaid managed care plan, and combined. We included Medicaid enrollees who had an in-person healthcare encounter during an influenza season in this period, excluding those under 6 months of age, over 65 years, or having telehealth-only encounters. Vaccination was the primary outcome, with secondary outcomes involving in-person healthcare encounters. Chi-square tests, multivariable logistic regression, and Fisher's exact test were utilized for statistical analysis. A total of 20,868,910 enrollees with at least one healthcare encounter in at least one influenza season were included in the study population between 2016 and 2021. Overall, 15% (N = 3,050,471) of enrollees received an influenza vaccine between 2016 and 2021. During peri-COVID periods, there was an increase in vaccination rates among enrollees compared to pre-COVID periods, from 14% to 16%. Children had the highest influenza vaccination rates among all age groups at 29%, whereas only 17% were of 5-17 years, and 10% were of the 18-64 years were vaccinated. We observed differences in the likelihood of receiving the influenza vaccine among enrollees based on their health conditions and medical encounters. In a study of Medicaid enrollees across nine states, 15% received an influenza vaccine from July 2016 to June 2021. Vaccination rates rose annually, peaking during peri-COVID seasons. The highest uptake was among children (6 months-4 years), and the lowest was in adults (18-64 years). Female gender, urban residency, and Medicaid-managed care affiliation positively influenced uptake. However, mental health and substance abuse disorders decreased the likelihood. This study, reliant on Medicaid claims data, underscores the need for outreach services.
季节性流感是美国主要的死亡原因之一,会导致严重的发病率、死亡率和经济负担。尽管疫苗接种已被证明有效,但接种率仍然显著偏低,尤其是在医疗补助计划参保者中。本研究利用医疗补助计划理赔数据,对医疗补助计划参保者的流感疫苗接种率进行了特征描述,并旨在阐明影响疫苗接种率的因素,提供可能也适用于其他疫苗可预防疾病(包括新冠病毒病)的见解。本研究使用了来自美国九个州(2016 - 2021年)的医疗补助计划理赔数据,涵盖三种理赔类型:按服务收费、主要医疗补助管理式医疗计划以及两者结合。我们纳入了在此期间流感季节有过面对面医疗就诊的医疗补助计划参保者,不包括6个月以下、65岁以上或仅进行远程医疗就诊的人群。疫苗接种是主要结果,次要结果涉及面对面医疗就诊。使用卡方检验、多变量逻辑回归和费舍尔精确检验进行统计分析。2016年至2021年期间,共有20,868,910名在至少一个流感季节有过至少一次医疗就诊的参保者被纳入研究人群。总体而言,2016年至2021年期间,15%(N = 3,050,471)的参保者接种了流感疫苗。在新冠疫情期间,参保者的接种率相比疫情前有所上升,从14%升至16%。所有年龄组中,儿童的流感疫苗接种率最高,为29%,而5 - 17岁的接种率仅为17%,18 - 64岁的接种率为10%。我们观察到,根据参保者的健康状况和医疗就诊情况,他们接种流感疫苗的可能性存在差异。在一项对九个州医疗补助计划参保者的研究中,2016年7月至2021年6月期间,15%的参保者接种了流感疫苗。接种率逐年上升,在新冠疫情期间达到峰值。接种率最高的是儿童(6个月至4岁),最低的是成年人(18 - 64岁)。女性、城市居住以及医疗补助管理式医疗关系对疫苗接种有积极影响。然而,精神健康和药物滥用障碍会降低接种可能性。这项依赖医疗补助计划理赔数据的研究强调了推广服务的必要性。